GSE132325
Sequencing of iMDK-treated regenerating limbs
Treatment with midkine inhibitor iMDK inhibits limb regeneration. To elucidate the transcriptional mechanisms of iMDK treatment, we sequenced regenerating limbs treated with either DMSO or iMDK (bulk) in biological triplicate at 11 days post-amputation (dpa). Overall design: Limbs were treated with iMDK or DMSO beginning immediately post-amputation up until the collection point at 11 dpa.